Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
39
BIO.B Quote, Financials, Valuation and Earnings
Last price:
$298.30
Seasonality move
:
2.25%
Day range:
$310.70 - $310.70
52-week range:
$225.29 - $359.22
Dividend yield:
0%
P/E ratio:
25.83x
P/S ratio:
3.21x
P/B ratio:
1.19x
Volume:
10
Avg. volume:
27
1-year change:
-4.65%
Market cap:
$8B
Revenue:
$2.6B
EPS (TTM):
-$24.31
Earnings Data
Next earnings date for BIO.B
Feb 12
2026
Most recent earnings per share
-$12.70
Missed by $12.70
(Oct 29/2025)
Consensus Estimate
--
(Oct 29/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
BIO.B Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/12/2026 | Q4 | $694.6M | -- | -- | -- | -- |
| 10/29/2025 | Q3 | $651.3M | $653M | -$12.70 | -- | -- |
| 07/31/2025 | Q2 | $614.3M | $651.6M | $11.67 | -- | -- |
| 05/01/2025 | Q1 | $573.2M | $585.4M | $2.29 | -- | -- |
| 02/13/2025 | Q4 | $679.8M | $667.5M | -$25.57 | -- | -- |
| 10/30/2024 | Q3 | $628.6M | $649.7M | $23.34 | -- | -- |
| 08/01/2024 | Q2 | $646.4M | $638.5M | -$76.26 | -- | -- |
| 05/07/2024 | Q1 | $620.1M | $610.8M | $13.45 | -- | -- |
| 02/15/2024 | Q4 | $686.6M | $681.2M | $12.14 | -- | -- |
| 10/26/2023 | Q3 | -- | $632.1M | $3.64 | -- | -- |
| 06/30/2023 | Q2 | -- | $681.1M | -$39.59 | -- | -- |
| 03/31/2023 | Q1 | -- | $676.8M | $2.32 | -- | -- |
| 12/31/2022 | Q4 | -- | $730.3M | $27.78 | -- | -- |
| 09/30/2022 | Q3 | -- | $680.8M | -$5.48 | -- | -- |
| 06/30/2022 | Q2 | -- | $691.1M | -$31.05 | -- | -- |
| 03/31/2022 | Q1 | -- | $700.1M | -$112.50 | -- | -- |
| 12/31/2021 | Q4 | -- | $732.8M | -$52.54 | -- | -- |
| 09/30/2021 | Q3 | -- | $747M | $129.96 | -- | -- |
| 06/30/2021 | Q2 | -- | $715.9M | $30.32 | -- | -- |
| 03/31/2021 | Q1 | -- | $726.8M | $32.38 | -- | -- |
| 12/31/2020 | Q4 | -- | $789.8M | $27.81 | -- | -- |
| 09/30/2020 | Q3 | -- | $647.3M | $43.64 | -- | -- |
| 06/30/2020 | Q2 | -- | $536.9M | $32.15 | -- | -- |
| 03/31/2020 | Q1 | -- | $571.6M | $22.72 | -- | -- |
| 12/31/2019 | Q4 | -- | $624.4M | $18.31 | -- | -- |
| 09/30/2019 | Q3 | -- | $560.6M | -$8.68 | -- | -- |
| 06/30/2019 | Q2 | -- | $572.6M | $19.86 | -- | -- |
| 03/31/2019 | Q1 | -- | $554M | $28.74 | -- | -- |
| 12/31/2018 | Q4 | -- | $617.5M | -$27.89 | -- | -- |
| 09/30/2018 | Q3 | -- | $545.1M | $8.89 | -- | -- |
| 06/30/2018 | Q2 | -- | $575.9M | $8.87 | -- | -- |
| 03/31/2018 | Q1 | -- | $551.5M | $21.77 | -- | -- |
| 12/31/2017 | Q4 | -- | $621.3M | $2.75 | -- | -- |
| 09/30/2017 | Q3 | -- | $534.1M | $0.73 | -- | -- |
| 06/30/2017 | Q2 | -- | $504.7M | $0.17 | -- | -- |
| 03/31/2017 | Q1 | -- | $500.1M | $0.42 | -- | -- |
| 12/31/2016 | Q4 | -- | $571.5M | -$0.70 | -- | -- |
| 09/30/2016 | Q3 | -- | $508.7M | $0.62 | -- | -- |
| 06/30/2016 | Q2 | -- | $516.8M | $0.61 | -- | -- |
| 03/31/2016 | Q1 | -- | $471.2M | $0.42 | -- | -- |
| 12/31/2015 | Q4 | -- | $570.6M | $1.68 | -- | -- |
Bio-Rad Laboratories, Inc. Earnings Questions
-
How Much did Bio-Rad Laboratories, Inc. Generate in Revenue Last Quarter?
Bio-Rad Laboratories, Inc. reported $653M worth of top line sales in its most recent quarter.
-
Did Bio-Rad Laboratories, Inc. Beat Earnings Last Quarter?
Bio-Rad Laboratories, Inc. announced earnings per share of -$12.70 which represents a miss of analyst forecast a -- per share.
-
Is Bio-Rad Laboratories, Inc. Profitable?
Bio-Rad Laboratories, Inc. reported $342.8M that represents $12.73 per share over the last quarter.
-
What is the Analyst Consensus for Bio-Rad Laboratories, Inc. EPS Next Year?
Bio-Rad Laboratories, Inc.'s earnings are forecast to grow from -$65.36 per share to -- per share next year representing an increase of --.
-
When is Bio-Rad Laboratories, Inc.'s Earnings Date?
Bio-Rad Laboratories, Inc.'s next earnings date is February 12, 2026.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
85
HUT alert for Dec 25
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
63
GPCR alert for Dec 25
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.
